Maersk, a bellwether for global trade, cuts container market outlook on U.S.-China tariff tensions

Maersk, a bellwether for global trade, cuts container market outlook on U.S.-China tariff tensions


The Maersk Alfirk, left, and Colorado Express container ships docked at the Port of Los Angeles in Los Angeles, California, US, on Thursday, April 24, 2025.

Bloomberg | Bloomberg | Getty Images

Danish shipping giant Maersk on Thursday posted stronger-than-expected first-quarter operating profit but warned that the current level of U.S.-China trade tariffs could restrict global container market volumes.

The company, widely regarded as a barometer of global trade, reported preliminary underlying earnings before interest, tax, depreciation and amortization (EBITDA) of $2.71 billion for the first three months of the year.

That’s up 70% from $1.59 billion over the same period a year earlier and above the $2.57 billion expected by analysts in an LSEG poll.

Maersk kept its 2025 profit guidance unchanged at between $6 billion and $9 billion but said global container market volume growth in 2025 had been revised to -1% to 4% “given the increased macroeconomic and geopolitical uncertainty.” Maersk had previously forecast container volume growth of 4% in 2025.

The results come as the shipping industry continues to navigate a complex tariff landscape sparked by U.S. President Donald Trump’s administration.

Trump’s current policy includes 145% import duties on products from China, prompting Beijing to hit back with tariffs on U.S. goods.

“The first quarter, actually, was a continuation of the very strong demand and very robust economy we had throughout last year. And so, on that strong demand, we were able to generate these really solid results,” Maersk CEO Vincent Clerc told CNBC’s “Squawk Box Europe” on Thursday.

Maersk CEO says ‘prohibitive’ U.S.-China tariffs to weigh on the global container market

“These results were also the fruit of strong preparation for what would come ahead. We knew it was going to be bumpy and indeed following April 2 announcement, things got a bit more bumpy,” he continued.

“The key thing for us is that as it is today, this is mostly a China-U.S. issue and it has not yet contaminated any of the other trade lanes – either from other origins and destinations with the U.S. or China or even for what the rest of the world trades together,” Clerc said.

‘A lot of volatility ahead’

On container market volumes, however, Clerc said the size and rapid escalation of U.S.-China tariffs has led to a sharp correction.

China-U.S. container market volumes have dropped between 30% to 40% in April as customers take a wait-and-see approach to the tariff situation, the company said.

“Unless we find a solution there then the current level of tariffs is simply prohibitive on both sides for it to really show some recovery. So, quite a targeted impact so far,” Clerc said, adding that he expects “a lot of volatility ahead.”

Disruption in the Red Sea is expected to continue throughout the rest of the year, Maersk said.

Shares of the company traded 2.2% lower at around 9:45 a.m. London time.



Source

Jury selection kicks off in Musk v. Altman trial
World

Jury selection kicks off in Musk v. Altman trial

A combination image shows Sam Altman, CEO of OpenAI, during the Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S., on November 16, 2023 and Elon Musk, Chief Executive Officer of SpaceX and Tesla and owner of X, formerly known as Twitter during Viva Technology conference dedicated to innovation and startups at the […]

Read More
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
World

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a) […]

Read More
Former Google DeepMind researcher’s AI startup raises record .1 billion seed funding to pursue superintelligence
World

Former Google DeepMind researcher’s AI startup raises record $1.1 billion seed funding to pursue superintelligence

A former top researcher at Google AI division DeepMind announced Monday a record $1.1 billion seed round for his months-old startup Ineffable Intelligence. The startup is pursuing superintelligence and was founded in late 2025 by UCL professor and former lead of DeepMind’s reinforcement learning team David Silver. The seed round is the largest ever in […]

Read More